McKesson Europe AG

McKesson Europe AG

CAKFY
McKesson Europe AGUS flagOther OTC
4.10
USD
- -
- -
5.37BMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Tilo Köster
Full Time Employees
26,329
Sector
Healthcare
Industry
Medical - Distribution
Address
Stockholmer Platz 1 Stuttgart Germany 70173
IPO Date
Feb 16, 2010
Business
McKesson Europe AG (CAKFY), headquartered in Stuttgart, Germany and founded in 1835 as Gehe & Co., operates as a leading provider of pharmaceutical wholesale, retail pharmacy services, and healthcare logistics across multiple European countries including Germany, the United Kingdom, Norway, Austria, and Denmark; its core offerings encompass pharmaceutical distribution to over 50,000 pharmacies and hospitals via 116 wholesale branches, IT platforms and cooperations for pharmacists, services for suppliers and manufacturers in the pharmaceutical sector, retail and mail-order pharmacies, home care solutions, and wound care products through subsidiaries such as recucare GmbH. The company structures its activities into Pharmacy Solutions, focusing on wholesale and ancillary services in nine countries, and Consumer Solutions, targeting patients with approximately 1,900 owned retail pharmacies and 6,900 partner pharmacies in select markets. McKesson Europe AG, majority-owned by McKesson Corporation, maintains a minority stake in a German joint venture with Walgreens Boots Alliance following the 2019 contribution of its GEHE Pharma Handel GmbH wholesale business. In recent strategic shifts, McKesson Corporation completed the sale of significant portions of McKesson Europe—including operations in France, Italy, Ireland, Portugal, Belgium, and Slovenia, the Stuttgart headquarters, the Lithuanian shared services center, and the 45% stake in Dutch joint venture Brocacef—to the PHOENIX group in October 2022, enabling a streamlined focus on remaining European assets while exploring further divestitures in the UK, Norway, Austria, and Denmark.